Physician profile
Jay Cook
NPI 1447287040
$1,093.91
in general payments reported to CMS, 2019-2025
12 companies · $143 in 2025
The $143 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $314 · 2021: $345 · 2022: $58.43 · 2024: $77.44 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $220.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $339.70 | 2020-2021 | |
| Abbvie INC. | $220.92 | 2024-2025 | |
| Ucb, INC. | $129.65 | 2019-2022 | |
| Biogen, INC. | $99.98 | 2021 | |
| Csl Behring | $85.80 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $57.95 | 2021 | |
| Neurelis, INC. | $55.81 | 2020-2021 | |
| Greenwich Biosciences, INC. | $52.26 | 2019 | |
| Alnylam Pharmaceuticals INC. | $22.86 | 2022 | |
| Shire North American Group INC | $15.96 | 2019 | |
| Genentech USA, INC. | $12.19 | 2022 | |
| Travere Therapeutics, INC. | $0.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.